Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 1-8 , September 2006

IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE

  • Emma J. O’Neill

      Affiliations

    • School of Agriculture, Food Science and Veterinary Medicine, College of Life Sciences, Belfield, Dublin 4, Ireland
    • Corresponding Author InformationCorresponding author. Tel.: +353 1716 6025; fax: +353 1716 6023.
    • ,
  • Michael J. Day

      Affiliations

    • Division of Veterinary Pathology, Infection and Immunity, Department of Clinical Veterinary Science, University of Bristol, Langford House, Langford, BS40 5DU, UK
    • ,
  • David C. Wraith

      Affiliations

    • Department of Cellular and Molecular Medicine, University of Bristol, Medical School, University Walk, Bristol BS8 1TD, UK

Received 24 February 2006 ,Revised 23 May 2006 ,Accepted 26 May 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0165-5728(06)00210-4

doi: 10.1016/j.jneuroim.2006.05.030

Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 1-8 , September 2006

Article Tools

* Image Usage & Resolution